Yasuhiro Imaeda
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Molecular Biology top 10%
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- Histone Deacetylase Inhibitors Research
- RNA Research and Splicing
Papers in
-
- Protein Degradation and Inhibitors 4
- RNA and protein synthesis mechanisms 4
- RNA Research and Splicing 3
-
- Synthesis and Catalytic Reactions 4
- Co-authors
- Nobuo Cho (5 shared papers)Mikihiko Naito (4 shared papers)Nobumichi Ohoka (4 shared papers)Katsunori Nagai (4 shared papers)Takayuki Hattori (4 shared papers)Norihito Shibata (4 shared papers)Hiroshi Nara (4 shared papers)Osamu Sano (4 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry (7 papers)Journal of Medicinal Chemistry (7 papers)Blood (2 papers)Biochemical and Biophysical Research Communications (2 papers)ACS Medicinal Chemistry Letters (2 papers)
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Yasuhiro Imaeda
30 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 72
- Hematology 237
- Molecular Biology 840
- Oncology 286
- Internal Medicine 18
- Organic Chemistry 167
Countries citing papers authored by Yasuhiro Imaeda
This map shows the geographic impact of Yasuhiro Imaeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuhiro Imaeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuhiro Imaeda more than expected).
Fields of papers citing papers by Yasuhiro Imaeda
This network shows the impact of papers produced by Yasuhiro Imaeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuhiro Imaeda. The network helps show where Yasuhiro Imaeda may publish in the future.
Co-authors
The 25 scholars most cited alongside Yasuhiro Imaeda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 201 | |
| 2 | 2017 | 124 | |
| 3 | 2013 | 93 | |
| 4 | 2017 | 90 | |
| 5 | 2018 | 87 | |
| 6 | 1995 | 55 | |
| 7 | 2018 | 51 | |
| 8 | 2010 | 47 | |
| 9 | 2017 | 35 | |
| 10 | 2017 | 31 | |
| 11 | 2017 | 28 | |
| 12 | 2002 | 27 | |
| 13 | 2016 | 27 | |
| 14 | 2017 | 26 | |
| 15 | 2008 | 24 | |
| 16 | 2016 | 23 | |
| 17 | 2017 | 21 | |
| 18 | 2007 | 17 | |
| 19 | 2018 | 17 | |
| 20 | 2007 | 13 |
About Yasuhiro Imaeda
Yasuhiro Imaeda is a scholar working on Molecular Biology, Organic Chemistry, Cardiology and Cardiovascular Medicine, Hematology and Oncology, having authored 30 papers that have together received 1.1k indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (7 papers), Protein Degradation and Inhibitors (4 papers), Renin-Angiotensin System Studies (4 papers), Synthesis and Catalytic Reactions (4 papers), RNA and protein synthesis mechanisms (4 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and RNA Research and Splicing (3 papers). The work is most often cited by research in Hematology (237 citations), Molecular Biology (840 citations), Oncology (286 citations), Internal Medicine (18 citations) and Organic Chemistry (167 citations). Yasuhiro Imaeda has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Nobuo Cho, Mikihiko Naito, Nobumichi Ohoka, Katsunori Nagai, Takayuki Hattori, Norihito Shibata, Hiroshi Nara, Osamu Sano, Masahiro Ito and Ryokichi Koyama. Their work appears in journals such as Bioorganic & Medicinal Chemistry, Journal of Medicinal Chemistry, Blood, Biochemical and Biophysical Research Communications and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.